These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32680964)

  • 1. Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling.
    Antonelli AC; Binyamin A; Hohl TM; Glickman MS; Redelman-Sidi G
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18627-18637. PubMed ID: 32680964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer.
    Gan YH; Zhang Y; Khoo HE; Esuvaranathan K
    Eur J Cancer; 1999 Jul; 35(7):1123-9. PubMed ID: 10533458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma.
    Arnold J; de Boer EC; O'Donnell MA; Böhle A; Brandau S
    J Immunother; 2004; 27(2):116-23. PubMed ID: 14770083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3/Nrf2 pathway.
    Mao MH; Huang HB; Zhang XL; Li K; Liu YL; Wang P
    Biomed Pharmacother; 2018 Nov; 107():1093-1103. PubMed ID: 30257321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical BCG Induces CD4
    Kates M; Nirschl T; Sopko NA; Matsui H; Kochel CM; Reis LO; Netto GJ; Hoque MO; Hahn NM; McConkey DJ; Baras AS; Drake CG; Bivalacqua TJ
    Cancer Immunol Res; 2017 Jul; 5(7):594-603. PubMed ID: 28588015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell subsets required for intravesical BCG immunotherapy for bladder cancer.
    Ratliff TL; Ritchey JK; Yuan JJ; Andriole GL; Catalona WJ
    J Urol; 1993 Sep; 150(3):1018-23. PubMed ID: 8102183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    Jpn J Cancer Res; 2000 May; 91(5):534-42. PubMed ID: 10835499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle.
    Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ
    Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.
    Luo Y; Chen X; Downs TM; DeWolf WC; O'Donnell MA
    J Immunol; 1999 Feb; 162(4):2399-405. PubMed ID: 9973521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific CD4 T cells are induced after intravesical BCG-instillation therapy in patients with bladder cancer and show similar cytokine profiles as in active tuberculosis.
    Elsäßer J; Janssen MW; Becker F; Suttmann H; Schmitt K; Sester U; Stöckle M; Sester M
    PLoS One; 2013; 8(9):e69892. PubMed ID: 24039703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model.
    Yoshino T; Miyazaki J; Kojima T; Kandori S; Shiga M; Kawahara T; Kimura T; Naka T; Kiyohara H; Watanabe M; Yamasaki S; Akaza H; Yano I; Nishiyama H
    PLoS One; 2019; 14(1):e0209196. PubMed ID: 30608942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lymphocytic responses after treatment with Bacillus Calmette-Guerin and interferon-alpha 2b for superficial bladder cancer.
    Gan YH; Mahendran R; James K; Lawrencia C; Esuvaranathan K
    Clin Immunol; 1999 Feb; 90(2):230-7. PubMed ID: 10080835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review.
    Patard JJ; Saint F; Velotti F; Abbou CC; Chopin DK
    Urol Res; 1998; 26(3):155-9. PubMed ID: 9694595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells.
    Lattime EC; Gomella LG; McCue PA
    Cancer Res; 1992 Aug; 52(15):4286-90. PubMed ID: 1638541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
    Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
    J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade.
    Sato Y; Bolzenius JK; Eteleeb AM; Su X; Maher CA; Sehn JK; Arora VK
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells.
    Cho MJ; Kim MJ; Kim K; Choi YW; Lee SJ; Whang YM; Chang IH
    Biochem Biophys Res Commun; 2019 Jan; 509(1):167-174. PubMed ID: 30579607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer Anti-Tumor Activity Can Be Achieved by
    Esteso G; Aguiló N; Julián E; Ashiru O; Ho MM; Martín C; Valés-Gómez M
    Front Immunol; 2021; 12():622995. PubMed ID: 33708215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.